| Roadways To Recovery Inc., | |
|
2620 Industrial Park Drive Bedford IN 47421 | |
| (812) 583-6540 | |
| Not Available |
| Full Name | Roadways To Recovery Inc., |
|---|---|
| Speciality | Clinic/Center |
| Location | 2620 Industrial Park Drive, Bedford, Indiana |
| Authorized Official Name and Position | Michael Coryea (OWNER) |
| Authorized Official Contact | 8125836540 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Roadways To Recovery Inc., 211 Stevens Ln Mitchell IN 47446-6606 Ph: (812) 583-6540 | Roadways To Recovery Inc., 2620 Industrial Park Drive Bedford IN 47421 Ph: (812) 583-6540 |
| NPI Number | 1740856483 |
|---|---|
| Provider Enumeration Date | 06/02/2021 |
| Last Update Date | 02/29/2024 |
| Certification Date | 02/29/2024 |
| Medicare PECOS PAC ID | 0143613695 |
|---|---|
| Medicare Enrollment ID | O20220207000825 |
News Archive
The Michael J. Fox Foundation has launched the Parkinson's Progression Markers Initiative (PPMI), the first ever large scale clinical study exclusively focused on identifying and validating Parkinson's disease biomarkers.
The lack of new or repurposed drugs to treat patients with severe or critical COVID-19 has been one of the biggest hurdles to reducing mortality rates in the ongoing pandemic caused by SARS-CoV-2. A new study describes the potential for the use of the plant molecule isorhamnetin in the management of this virus.
Pharmaceutical Training International (PTI), the leading supplier of online and public event-based training courses for the pharma, biotech and medical device sectors, is launching a series of easy-access and cost–effective webinar e-courses to guide pharma professionals through the industry challenges they face.
GlaxoSmithKline (GSK) had teamed up with leading public-domain data providers European Bioinformatics Institute (EMBL-EBI), the U.S. National Library of Medicine (NLM) and the U.S.-based informatics service provider Collaborative Drug Discovery (CDD) to make freely available key scientific information on more than 13,500 compounds that could ultimately lead to new treatments for malaria.
Over three days of festivities Scotland's NHS 24 has received almost 30,000 calls. This made 27th of December NHS 24's busiest day since January 2007. The surge in demand for the service was due to the closure of GP surgeries over the festive weekend.
› Verified 8 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1740856483 | NPI | - | NPPES |
| Provider Name | Vahid Osman |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1740264720 PECOS PAC ID: 2264409010 Enrollment ID: I20040913000512 |
News Archive
The Michael J. Fox Foundation has launched the Parkinson's Progression Markers Initiative (PPMI), the first ever large scale clinical study exclusively focused on identifying and validating Parkinson's disease biomarkers.
The lack of new or repurposed drugs to treat patients with severe or critical COVID-19 has been one of the biggest hurdles to reducing mortality rates in the ongoing pandemic caused by SARS-CoV-2. A new study describes the potential for the use of the plant molecule isorhamnetin in the management of this virus.
Pharmaceutical Training International (PTI), the leading supplier of online and public event-based training courses for the pharma, biotech and medical device sectors, is launching a series of easy-access and cost–effective webinar e-courses to guide pharma professionals through the industry challenges they face.
GlaxoSmithKline (GSK) had teamed up with leading public-domain data providers European Bioinformatics Institute (EMBL-EBI), the U.S. National Library of Medicine (NLM) and the U.S.-based informatics service provider Collaborative Drug Discovery (CDD) to make freely available key scientific information on more than 13,500 compounds that could ultimately lead to new treatments for malaria.
Over three days of festivities Scotland's NHS 24 has received almost 30,000 calls. This made 27th of December NHS 24's busiest day since January 2007. The surge in demand for the service was due to the closure of GP surgeries over the festive weekend.
› Verified 8 days ago
| Provider Name | Emily A Kramer |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1770506339 PECOS PAC ID: 0345304796 Enrollment ID: I20090129000204 |
News Archive
The Michael J. Fox Foundation has launched the Parkinson's Progression Markers Initiative (PPMI), the first ever large scale clinical study exclusively focused on identifying and validating Parkinson's disease biomarkers.
The lack of new or repurposed drugs to treat patients with severe or critical COVID-19 has been one of the biggest hurdles to reducing mortality rates in the ongoing pandemic caused by SARS-CoV-2. A new study describes the potential for the use of the plant molecule isorhamnetin in the management of this virus.
Pharmaceutical Training International (PTI), the leading supplier of online and public event-based training courses for the pharma, biotech and medical device sectors, is launching a series of easy-access and cost–effective webinar e-courses to guide pharma professionals through the industry challenges they face.
GlaxoSmithKline (GSK) had teamed up with leading public-domain data providers European Bioinformatics Institute (EMBL-EBI), the U.S. National Library of Medicine (NLM) and the U.S.-based informatics service provider Collaborative Drug Discovery (CDD) to make freely available key scientific information on more than 13,500 compounds that could ultimately lead to new treatments for malaria.
Over three days of festivities Scotland's NHS 24 has received almost 30,000 calls. This made 27th of December NHS 24's busiest day since January 2007. The surge in demand for the service was due to the closure of GP surgeries over the festive weekend.
› Verified 8 days ago
| Provider Name | Jayme Albin |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1760800320 PECOS PAC ID: 0446555692 Enrollment ID: I20160225000987 |
News Archive
The Michael J. Fox Foundation has launched the Parkinson's Progression Markers Initiative (PPMI), the first ever large scale clinical study exclusively focused on identifying and validating Parkinson's disease biomarkers.
The lack of new or repurposed drugs to treat patients with severe or critical COVID-19 has been one of the biggest hurdles to reducing mortality rates in the ongoing pandemic caused by SARS-CoV-2. A new study describes the potential for the use of the plant molecule isorhamnetin in the management of this virus.
Pharmaceutical Training International (PTI), the leading supplier of online and public event-based training courses for the pharma, biotech and medical device sectors, is launching a series of easy-access and cost–effective webinar e-courses to guide pharma professionals through the industry challenges they face.
GlaxoSmithKline (GSK) had teamed up with leading public-domain data providers European Bioinformatics Institute (EMBL-EBI), the U.S. National Library of Medicine (NLM) and the U.S.-based informatics service provider Collaborative Drug Discovery (CDD) to make freely available key scientific information on more than 13,500 compounds that could ultimately lead to new treatments for malaria.
Over three days of festivities Scotland's NHS 24 has received almost 30,000 calls. This made 27th of December NHS 24's busiest day since January 2007. The surge in demand for the service was due to the closure of GP surgeries over the festive weekend.
› Verified 8 days ago
| Provider Name | Melinda K Bruner |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1780138149 PECOS PAC ID: 7315233475 Enrollment ID: I20160915002175 |
News Archive
The Michael J. Fox Foundation has launched the Parkinson's Progression Markers Initiative (PPMI), the first ever large scale clinical study exclusively focused on identifying and validating Parkinson's disease biomarkers.
The lack of new or repurposed drugs to treat patients with severe or critical COVID-19 has been one of the biggest hurdles to reducing mortality rates in the ongoing pandemic caused by SARS-CoV-2. A new study describes the potential for the use of the plant molecule isorhamnetin in the management of this virus.
Pharmaceutical Training International (PTI), the leading supplier of online and public event-based training courses for the pharma, biotech and medical device sectors, is launching a series of easy-access and cost–effective webinar e-courses to guide pharma professionals through the industry challenges they face.
GlaxoSmithKline (GSK) had teamed up with leading public-domain data providers European Bioinformatics Institute (EMBL-EBI), the U.S. National Library of Medicine (NLM) and the U.S.-based informatics service provider Collaborative Drug Discovery (CDD) to make freely available key scientific information on more than 13,500 compounds that could ultimately lead to new treatments for malaria.
Over three days of festivities Scotland's NHS 24 has received almost 30,000 calls. This made 27th of December NHS 24's busiest day since January 2007. The surge in demand for the service was due to the closure of GP surgeries over the festive weekend.
› Verified 8 days ago
| Provider Name | Lindsay Lindsey |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1558810366 PECOS PAC ID: 7214215151 Enrollment ID: I20161028000422 |
News Archive
The Michael J. Fox Foundation has launched the Parkinson's Progression Markers Initiative (PPMI), the first ever large scale clinical study exclusively focused on identifying and validating Parkinson's disease biomarkers.
The lack of new or repurposed drugs to treat patients with severe or critical COVID-19 has been one of the biggest hurdles to reducing mortality rates in the ongoing pandemic caused by SARS-CoV-2. A new study describes the potential for the use of the plant molecule isorhamnetin in the management of this virus.
Pharmaceutical Training International (PTI), the leading supplier of online and public event-based training courses for the pharma, biotech and medical device sectors, is launching a series of easy-access and cost–effective webinar e-courses to guide pharma professionals through the industry challenges they face.
GlaxoSmithKline (GSK) had teamed up with leading public-domain data providers European Bioinformatics Institute (EMBL-EBI), the U.S. National Library of Medicine (NLM) and the U.S.-based informatics service provider Collaborative Drug Discovery (CDD) to make freely available key scientific information on more than 13,500 compounds that could ultimately lead to new treatments for malaria.
Over three days of festivities Scotland's NHS 24 has received almost 30,000 calls. This made 27th of December NHS 24's busiest day since January 2007. The surge in demand for the service was due to the closure of GP surgeries over the festive weekend.
› Verified 8 days ago
| Provider Name | Michael Coryea |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1366985046 PECOS PAC ID: 3375828577 Enrollment ID: I20170331000273 |
News Archive
The Michael J. Fox Foundation has launched the Parkinson's Progression Markers Initiative (PPMI), the first ever large scale clinical study exclusively focused on identifying and validating Parkinson's disease biomarkers.
The lack of new or repurposed drugs to treat patients with severe or critical COVID-19 has been one of the biggest hurdles to reducing mortality rates in the ongoing pandemic caused by SARS-CoV-2. A new study describes the potential for the use of the plant molecule isorhamnetin in the management of this virus.
Pharmaceutical Training International (PTI), the leading supplier of online and public event-based training courses for the pharma, biotech and medical device sectors, is launching a series of easy-access and cost–effective webinar e-courses to guide pharma professionals through the industry challenges they face.
GlaxoSmithKline (GSK) had teamed up with leading public-domain data providers European Bioinformatics Institute (EMBL-EBI), the U.S. National Library of Medicine (NLM) and the U.S.-based informatics service provider Collaborative Drug Discovery (CDD) to make freely available key scientific information on more than 13,500 compounds that could ultimately lead to new treatments for malaria.
Over three days of festivities Scotland's NHS 24 has received almost 30,000 calls. This made 27th of December NHS 24's busiest day since January 2007. The surge in demand for the service was due to the closure of GP surgeries over the festive weekend.
› Verified 8 days ago
| Provider Name | Kimberly Hizer |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1528614047 PECOS PAC ID: 8022347822 Enrollment ID: I20190904000418 |
News Archive
The Michael J. Fox Foundation has launched the Parkinson's Progression Markers Initiative (PPMI), the first ever large scale clinical study exclusively focused on identifying and validating Parkinson's disease biomarkers.
The lack of new or repurposed drugs to treat patients with severe or critical COVID-19 has been one of the biggest hurdles to reducing mortality rates in the ongoing pandemic caused by SARS-CoV-2. A new study describes the potential for the use of the plant molecule isorhamnetin in the management of this virus.
Pharmaceutical Training International (PTI), the leading supplier of online and public event-based training courses for the pharma, biotech and medical device sectors, is launching a series of easy-access and cost–effective webinar e-courses to guide pharma professionals through the industry challenges they face.
GlaxoSmithKline (GSK) had teamed up with leading public-domain data providers European Bioinformatics Institute (EMBL-EBI), the U.S. National Library of Medicine (NLM) and the U.S.-based informatics service provider Collaborative Drug Discovery (CDD) to make freely available key scientific information on more than 13,500 compounds that could ultimately lead to new treatments for malaria.
Over three days of festivities Scotland's NHS 24 has received almost 30,000 calls. This made 27th of December NHS 24's busiest day since January 2007. The surge in demand for the service was due to the closure of GP surgeries over the festive weekend.
› Verified 8 days ago
| Provider Name | Amy Schafer |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1013566132 PECOS PAC ID: 5799016960 Enrollment ID: I20191021000486 |
News Archive
The Michael J. Fox Foundation has launched the Parkinson's Progression Markers Initiative (PPMI), the first ever large scale clinical study exclusively focused on identifying and validating Parkinson's disease biomarkers.
The lack of new or repurposed drugs to treat patients with severe or critical COVID-19 has been one of the biggest hurdles to reducing mortality rates in the ongoing pandemic caused by SARS-CoV-2. A new study describes the potential for the use of the plant molecule isorhamnetin in the management of this virus.
Pharmaceutical Training International (PTI), the leading supplier of online and public event-based training courses for the pharma, biotech and medical device sectors, is launching a series of easy-access and cost–effective webinar e-courses to guide pharma professionals through the industry challenges they face.
GlaxoSmithKline (GSK) had teamed up with leading public-domain data providers European Bioinformatics Institute (EMBL-EBI), the U.S. National Library of Medicine (NLM) and the U.S.-based informatics service provider Collaborative Drug Discovery (CDD) to make freely available key scientific information on more than 13,500 compounds that could ultimately lead to new treatments for malaria.
Over three days of festivities Scotland's NHS 24 has received almost 30,000 calls. This made 27th of December NHS 24's busiest day since January 2007. The surge in demand for the service was due to the closure of GP surgeries over the festive weekend.
› Verified 8 days ago
| Provider Name | Elijah Wilder |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1083976971 PECOS PAC ID: 9133496193 Enrollment ID: I20201030001378 |
News Archive
The Michael J. Fox Foundation has launched the Parkinson's Progression Markers Initiative (PPMI), the first ever large scale clinical study exclusively focused on identifying and validating Parkinson's disease biomarkers.
The lack of new or repurposed drugs to treat patients with severe or critical COVID-19 has been one of the biggest hurdles to reducing mortality rates in the ongoing pandemic caused by SARS-CoV-2. A new study describes the potential for the use of the plant molecule isorhamnetin in the management of this virus.
Pharmaceutical Training International (PTI), the leading supplier of online and public event-based training courses for the pharma, biotech and medical device sectors, is launching a series of easy-access and cost–effective webinar e-courses to guide pharma professionals through the industry challenges they face.
GlaxoSmithKline (GSK) had teamed up with leading public-domain data providers European Bioinformatics Institute (EMBL-EBI), the U.S. National Library of Medicine (NLM) and the U.S.-based informatics service provider Collaborative Drug Discovery (CDD) to make freely available key scientific information on more than 13,500 compounds that could ultimately lead to new treatments for malaria.
Over three days of festivities Scotland's NHS 24 has received almost 30,000 calls. This made 27th of December NHS 24's busiest day since January 2007. The surge in demand for the service was due to the closure of GP surgeries over the festive weekend.
› Verified 8 days ago
| Provider Name | Christy Riddle |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1790918951 PECOS PAC ID: 7810393857 Enrollment ID: I20210831001228 |
News Archive
The Michael J. Fox Foundation has launched the Parkinson's Progression Markers Initiative (PPMI), the first ever large scale clinical study exclusively focused on identifying and validating Parkinson's disease biomarkers.
The lack of new or repurposed drugs to treat patients with severe or critical COVID-19 has been one of the biggest hurdles to reducing mortality rates in the ongoing pandemic caused by SARS-CoV-2. A new study describes the potential for the use of the plant molecule isorhamnetin in the management of this virus.
Pharmaceutical Training International (PTI), the leading supplier of online and public event-based training courses for the pharma, biotech and medical device sectors, is launching a series of easy-access and cost–effective webinar e-courses to guide pharma professionals through the industry challenges they face.
GlaxoSmithKline (GSK) had teamed up with leading public-domain data providers European Bioinformatics Institute (EMBL-EBI), the U.S. National Library of Medicine (NLM) and the U.S.-based informatics service provider Collaborative Drug Discovery (CDD) to make freely available key scientific information on more than 13,500 compounds that could ultimately lead to new treatments for malaria.
Over three days of festivities Scotland's NHS 24 has received almost 30,000 calls. This made 27th of December NHS 24's busiest day since January 2007. The surge in demand for the service was due to the closure of GP surgeries over the festive weekend.
› Verified 8 days ago
| Provider Name | Rinkoo Sidhu |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1497326649 PECOS PAC ID: 0143627018 Enrollment ID: I20210920001082 |
News Archive
The Michael J. Fox Foundation has launched the Parkinson's Progression Markers Initiative (PPMI), the first ever large scale clinical study exclusively focused on identifying and validating Parkinson's disease biomarkers.
The lack of new or repurposed drugs to treat patients with severe or critical COVID-19 has been one of the biggest hurdles to reducing mortality rates in the ongoing pandemic caused by SARS-CoV-2. A new study describes the potential for the use of the plant molecule isorhamnetin in the management of this virus.
Pharmaceutical Training International (PTI), the leading supplier of online and public event-based training courses for the pharma, biotech and medical device sectors, is launching a series of easy-access and cost–effective webinar e-courses to guide pharma professionals through the industry challenges they face.
GlaxoSmithKline (GSK) had teamed up with leading public-domain data providers European Bioinformatics Institute (EMBL-EBI), the U.S. National Library of Medicine (NLM) and the U.S.-based informatics service provider Collaborative Drug Discovery (CDD) to make freely available key scientific information on more than 13,500 compounds that could ultimately lead to new treatments for malaria.
Over three days of festivities Scotland's NHS 24 has received almost 30,000 calls. This made 27th of December NHS 24's busiest day since January 2007. The surge in demand for the service was due to the closure of GP surgeries over the festive weekend.
› Verified 8 days ago
| Provider Name | Carrie Lynne Helle |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1184988388 PECOS PAC ID: 6002138344 Enrollment ID: I20211201002127 |
News Archive
The Michael J. Fox Foundation has launched the Parkinson's Progression Markers Initiative (PPMI), the first ever large scale clinical study exclusively focused on identifying and validating Parkinson's disease biomarkers.
The lack of new or repurposed drugs to treat patients with severe or critical COVID-19 has been one of the biggest hurdles to reducing mortality rates in the ongoing pandemic caused by SARS-CoV-2. A new study describes the potential for the use of the plant molecule isorhamnetin in the management of this virus.
Pharmaceutical Training International (PTI), the leading supplier of online and public event-based training courses for the pharma, biotech and medical device sectors, is launching a series of easy-access and cost–effective webinar e-courses to guide pharma professionals through the industry challenges they face.
GlaxoSmithKline (GSK) had teamed up with leading public-domain data providers European Bioinformatics Institute (EMBL-EBI), the U.S. National Library of Medicine (NLM) and the U.S.-based informatics service provider Collaborative Drug Discovery (CDD) to make freely available key scientific information on more than 13,500 compounds that could ultimately lead to new treatments for malaria.
Over three days of festivities Scotland's NHS 24 has received almost 30,000 calls. This made 27th of December NHS 24's busiest day since January 2007. The surge in demand for the service was due to the closure of GP surgeries over the festive weekend.
› Verified 8 days ago
| Provider Name | Kristin Miller |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1841578747 PECOS PAC ID: 5395162580 Enrollment ID: I20220719002978 |
News Archive
The Michael J. Fox Foundation has launched the Parkinson's Progression Markers Initiative (PPMI), the first ever large scale clinical study exclusively focused on identifying and validating Parkinson's disease biomarkers.
The lack of new or repurposed drugs to treat patients with severe or critical COVID-19 has been one of the biggest hurdles to reducing mortality rates in the ongoing pandemic caused by SARS-CoV-2. A new study describes the potential for the use of the plant molecule isorhamnetin in the management of this virus.
Pharmaceutical Training International (PTI), the leading supplier of online and public event-based training courses for the pharma, biotech and medical device sectors, is launching a series of easy-access and cost–effective webinar e-courses to guide pharma professionals through the industry challenges they face.
GlaxoSmithKline (GSK) had teamed up with leading public-domain data providers European Bioinformatics Institute (EMBL-EBI), the U.S. National Library of Medicine (NLM) and the U.S.-based informatics service provider Collaborative Drug Discovery (CDD) to make freely available key scientific information on more than 13,500 compounds that could ultimately lead to new treatments for malaria.
Over three days of festivities Scotland's NHS 24 has received almost 30,000 calls. This made 27th of December NHS 24's busiest day since January 2007. The surge in demand for the service was due to the closure of GP surgeries over the festive weekend.
› Verified 8 days ago
| Provider Name | Alex Qualkinbush |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1215664016 PECOS PAC ID: 2668855867 Enrollment ID: I20220822001518 |
News Archive
The Michael J. Fox Foundation has launched the Parkinson's Progression Markers Initiative (PPMI), the first ever large scale clinical study exclusively focused on identifying and validating Parkinson's disease biomarkers.
The lack of new or repurposed drugs to treat patients with severe or critical COVID-19 has been one of the biggest hurdles to reducing mortality rates in the ongoing pandemic caused by SARS-CoV-2. A new study describes the potential for the use of the plant molecule isorhamnetin in the management of this virus.
Pharmaceutical Training International (PTI), the leading supplier of online and public event-based training courses for the pharma, biotech and medical device sectors, is launching a series of easy-access and cost–effective webinar e-courses to guide pharma professionals through the industry challenges they face.
GlaxoSmithKline (GSK) had teamed up with leading public-domain data providers European Bioinformatics Institute (EMBL-EBI), the U.S. National Library of Medicine (NLM) and the U.S.-based informatics service provider Collaborative Drug Discovery (CDD) to make freely available key scientific information on more than 13,500 compounds that could ultimately lead to new treatments for malaria.
Over three days of festivities Scotland's NHS 24 has received almost 30,000 calls. This made 27th of December NHS 24's busiest day since January 2007. The surge in demand for the service was due to the closure of GP surgeries over the festive weekend.
› Verified 8 days ago
| Provider Name | Kacey Dawn Poe |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1740904002 PECOS PAC ID: 6002282712 Enrollment ID: I20221021000302 |
News Archive
The Michael J. Fox Foundation has launched the Parkinson's Progression Markers Initiative (PPMI), the first ever large scale clinical study exclusively focused on identifying and validating Parkinson's disease biomarkers.
The lack of new or repurposed drugs to treat patients with severe or critical COVID-19 has been one of the biggest hurdles to reducing mortality rates in the ongoing pandemic caused by SARS-CoV-2. A new study describes the potential for the use of the plant molecule isorhamnetin in the management of this virus.
Pharmaceutical Training International (PTI), the leading supplier of online and public event-based training courses for the pharma, biotech and medical device sectors, is launching a series of easy-access and cost–effective webinar e-courses to guide pharma professionals through the industry challenges they face.
GlaxoSmithKline (GSK) had teamed up with leading public-domain data providers European Bioinformatics Institute (EMBL-EBI), the U.S. National Library of Medicine (NLM) and the U.S.-based informatics service provider Collaborative Drug Discovery (CDD) to make freely available key scientific information on more than 13,500 compounds that could ultimately lead to new treatments for malaria.
Over three days of festivities Scotland's NHS 24 has received almost 30,000 calls. This made 27th of December NHS 24's busiest day since January 2007. The surge in demand for the service was due to the closure of GP surgeries over the festive weekend.
› Verified 8 days ago
| Provider Name | William Andrew Garriott |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1780346692 PECOS PAC ID: 9638548340 Enrollment ID: I20221219001857 |
News Archive
The Michael J. Fox Foundation has launched the Parkinson's Progression Markers Initiative (PPMI), the first ever large scale clinical study exclusively focused on identifying and validating Parkinson's disease biomarkers.
The lack of new or repurposed drugs to treat patients with severe or critical COVID-19 has been one of the biggest hurdles to reducing mortality rates in the ongoing pandemic caused by SARS-CoV-2. A new study describes the potential for the use of the plant molecule isorhamnetin in the management of this virus.
Pharmaceutical Training International (PTI), the leading supplier of online and public event-based training courses for the pharma, biotech and medical device sectors, is launching a series of easy-access and cost–effective webinar e-courses to guide pharma professionals through the industry challenges they face.
GlaxoSmithKline (GSK) had teamed up with leading public-domain data providers European Bioinformatics Institute (EMBL-EBI), the U.S. National Library of Medicine (NLM) and the U.S.-based informatics service provider Collaborative Drug Discovery (CDD) to make freely available key scientific information on more than 13,500 compounds that could ultimately lead to new treatments for malaria.
Over three days of festivities Scotland's NHS 24 has received almost 30,000 calls. This made 27th of December NHS 24's busiest day since January 2007. The surge in demand for the service was due to the closure of GP surgeries over the festive weekend.
› Verified 8 days ago
| Provider Name | Aaron J Mangin |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1699494153 PECOS PAC ID: 6608245378 Enrollment ID: I20221220001733 |
News Archive
The Michael J. Fox Foundation has launched the Parkinson's Progression Markers Initiative (PPMI), the first ever large scale clinical study exclusively focused on identifying and validating Parkinson's disease biomarkers.
The lack of new or repurposed drugs to treat patients with severe or critical COVID-19 has been one of the biggest hurdles to reducing mortality rates in the ongoing pandemic caused by SARS-CoV-2. A new study describes the potential for the use of the plant molecule isorhamnetin in the management of this virus.
Pharmaceutical Training International (PTI), the leading supplier of online and public event-based training courses for the pharma, biotech and medical device sectors, is launching a series of easy-access and cost–effective webinar e-courses to guide pharma professionals through the industry challenges they face.
GlaxoSmithKline (GSK) had teamed up with leading public-domain data providers European Bioinformatics Institute (EMBL-EBI), the U.S. National Library of Medicine (NLM) and the U.S.-based informatics service provider Collaborative Drug Discovery (CDD) to make freely available key scientific information on more than 13,500 compounds that could ultimately lead to new treatments for malaria.
Over three days of festivities Scotland's NHS 24 has received almost 30,000 calls. This made 27th of December NHS 24's busiest day since January 2007. The surge in demand for the service was due to the closure of GP surgeries over the festive weekend.
› Verified 8 days ago
| Provider Name | Heather Depaul |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1154032043 PECOS PAC ID: 6800266529 Enrollment ID: I20221221001064 |
News Archive
The Michael J. Fox Foundation has launched the Parkinson's Progression Markers Initiative (PPMI), the first ever large scale clinical study exclusively focused on identifying and validating Parkinson's disease biomarkers.
The lack of new or repurposed drugs to treat patients with severe or critical COVID-19 has been one of the biggest hurdles to reducing mortality rates in the ongoing pandemic caused by SARS-CoV-2. A new study describes the potential for the use of the plant molecule isorhamnetin in the management of this virus.
Pharmaceutical Training International (PTI), the leading supplier of online and public event-based training courses for the pharma, biotech and medical device sectors, is launching a series of easy-access and cost–effective webinar e-courses to guide pharma professionals through the industry challenges they face.
GlaxoSmithKline (GSK) had teamed up with leading public-domain data providers European Bioinformatics Institute (EMBL-EBI), the U.S. National Library of Medicine (NLM) and the U.S.-based informatics service provider Collaborative Drug Discovery (CDD) to make freely available key scientific information on more than 13,500 compounds that could ultimately lead to new treatments for malaria.
Over three days of festivities Scotland's NHS 24 has received almost 30,000 calls. This made 27th of December NHS 24's busiest day since January 2007. The surge in demand for the service was due to the closure of GP surgeries over the festive weekend.
› Verified 8 days ago
| Provider Name | Jessi Dean Todd |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1891420535 PECOS PAC ID: 1456723105 Enrollment ID: I20230207001998 |
News Archive
The Michael J. Fox Foundation has launched the Parkinson's Progression Markers Initiative (PPMI), the first ever large scale clinical study exclusively focused on identifying and validating Parkinson's disease biomarkers.
The lack of new or repurposed drugs to treat patients with severe or critical COVID-19 has been one of the biggest hurdles to reducing mortality rates in the ongoing pandemic caused by SARS-CoV-2. A new study describes the potential for the use of the plant molecule isorhamnetin in the management of this virus.
Pharmaceutical Training International (PTI), the leading supplier of online and public event-based training courses for the pharma, biotech and medical device sectors, is launching a series of easy-access and cost–effective webinar e-courses to guide pharma professionals through the industry challenges they face.
GlaxoSmithKline (GSK) had teamed up with leading public-domain data providers European Bioinformatics Institute (EMBL-EBI), the U.S. National Library of Medicine (NLM) and the U.S.-based informatics service provider Collaborative Drug Discovery (CDD) to make freely available key scientific information on more than 13,500 compounds that could ultimately lead to new treatments for malaria.
Over three days of festivities Scotland's NHS 24 has received almost 30,000 calls. This made 27th of December NHS 24's busiest day since January 2007. The surge in demand for the service was due to the closure of GP surgeries over the festive weekend.
› Verified 8 days ago
| Provider Name | Jessica Nicole Roberts |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1609578269 PECOS PAC ID: 2466810502 Enrollment ID: I20230621002364 |
News Archive
The Michael J. Fox Foundation has launched the Parkinson's Progression Markers Initiative (PPMI), the first ever large scale clinical study exclusively focused on identifying and validating Parkinson's disease biomarkers.
The lack of new or repurposed drugs to treat patients with severe or critical COVID-19 has been one of the biggest hurdles to reducing mortality rates in the ongoing pandemic caused by SARS-CoV-2. A new study describes the potential for the use of the plant molecule isorhamnetin in the management of this virus.
Pharmaceutical Training International (PTI), the leading supplier of online and public event-based training courses for the pharma, biotech and medical device sectors, is launching a series of easy-access and cost–effective webinar e-courses to guide pharma professionals through the industry challenges they face.
GlaxoSmithKline (GSK) had teamed up with leading public-domain data providers European Bioinformatics Institute (EMBL-EBI), the U.S. National Library of Medicine (NLM) and the U.S.-based informatics service provider Collaborative Drug Discovery (CDD) to make freely available key scientific information on more than 13,500 compounds that could ultimately lead to new treatments for malaria.
Over three days of festivities Scotland's NHS 24 has received almost 30,000 calls. This made 27th of December NHS 24's busiest day since January 2007. The surge in demand for the service was due to the closure of GP surgeries over the festive weekend.
› Verified 8 days ago
| Provider Name | Monica Light |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1295491512 PECOS PAC ID: 9436541752 Enrollment ID: I20230821003893 |
News Archive
The Michael J. Fox Foundation has launched the Parkinson's Progression Markers Initiative (PPMI), the first ever large scale clinical study exclusively focused on identifying and validating Parkinson's disease biomarkers.
The lack of new or repurposed drugs to treat patients with severe or critical COVID-19 has been one of the biggest hurdles to reducing mortality rates in the ongoing pandemic caused by SARS-CoV-2. A new study describes the potential for the use of the plant molecule isorhamnetin in the management of this virus.
Pharmaceutical Training International (PTI), the leading supplier of online and public event-based training courses for the pharma, biotech and medical device sectors, is launching a series of easy-access and cost–effective webinar e-courses to guide pharma professionals through the industry challenges they face.
GlaxoSmithKline (GSK) had teamed up with leading public-domain data providers European Bioinformatics Institute (EMBL-EBI), the U.S. National Library of Medicine (NLM) and the U.S.-based informatics service provider Collaborative Drug Discovery (CDD) to make freely available key scientific information on more than 13,500 compounds that could ultimately lead to new treatments for malaria.
Over three days of festivities Scotland's NHS 24 has received almost 30,000 calls. This made 27th of December NHS 24's busiest day since January 2007. The surge in demand for the service was due to the closure of GP surgeries over the festive weekend.
› Verified 8 days ago
| Provider Name | John Dixon |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1942641014 PECOS PAC ID: 2264676675 Enrollment ID: I20231003001561 |
News Archive
The Michael J. Fox Foundation has launched the Parkinson's Progression Markers Initiative (PPMI), the first ever large scale clinical study exclusively focused on identifying and validating Parkinson's disease biomarkers.
The lack of new or repurposed drugs to treat patients with severe or critical COVID-19 has been one of the biggest hurdles to reducing mortality rates in the ongoing pandemic caused by SARS-CoV-2. A new study describes the potential for the use of the plant molecule isorhamnetin in the management of this virus.
Pharmaceutical Training International (PTI), the leading supplier of online and public event-based training courses for the pharma, biotech and medical device sectors, is launching a series of easy-access and cost–effective webinar e-courses to guide pharma professionals through the industry challenges they face.
GlaxoSmithKline (GSK) had teamed up with leading public-domain data providers European Bioinformatics Institute (EMBL-EBI), the U.S. National Library of Medicine (NLM) and the U.S.-based informatics service provider Collaborative Drug Discovery (CDD) to make freely available key scientific information on more than 13,500 compounds that could ultimately lead to new treatments for malaria.
Over three days of festivities Scotland's NHS 24 has received almost 30,000 calls. This made 27th of December NHS 24's busiest day since January 2007. The surge in demand for the service was due to the closure of GP surgeries over the festive weekend.
› Verified 8 days ago
News Archive
The Michael J. Fox Foundation has launched the Parkinson's Progression Markers Initiative (PPMI), the first ever large scale clinical study exclusively focused on identifying and validating Parkinson's disease biomarkers.
The lack of new or repurposed drugs to treat patients with severe or critical COVID-19 has been one of the biggest hurdles to reducing mortality rates in the ongoing pandemic caused by SARS-CoV-2. A new study describes the potential for the use of the plant molecule isorhamnetin in the management of this virus.
Pharmaceutical Training International (PTI), the leading supplier of online and public event-based training courses for the pharma, biotech and medical device sectors, is launching a series of easy-access and cost–effective webinar e-courses to guide pharma professionals through the industry challenges they face.
GlaxoSmithKline (GSK) had teamed up with leading public-domain data providers European Bioinformatics Institute (EMBL-EBI), the U.S. National Library of Medicine (NLM) and the U.S.-based informatics service provider Collaborative Drug Discovery (CDD) to make freely available key scientific information on more than 13,500 compounds that could ultimately lead to new treatments for malaria.
Over three days of festivities Scotland's NHS 24 has received almost 30,000 calls. This made 27th of December NHS 24's busiest day since January 2007. The surge in demand for the service was due to the closure of GP surgeries over the festive weekend.
› Verified 8 days ago
Stone City Counseling, Inc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 2325 Q St, Bedford, IN 47421 Phone: 812-279-4673 Fax: 812-279-4672 | |
Stone City Counseling Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 2325 Q St, Bedford, IN 47421 Phone: 812-279-4673 | |
Nikkia Obannon Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 519 V St, Bedford, IN 47421 Phone: 812-276-5030 | |
Serenity Now Psychiatric & Counseling Services Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 2125 16th St, Bedford, IN 47421 Phone: 812-275-4053 | |
Family Matters Counseling And Consulting Llc Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 2809 Washington Ave, Suite R, Bedford, IN 47421 Phone: 812-278-8707 | |
Dunn Memorial Hospital Pysch Unit Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 1600 23rd St, Bedford, IN 47421 Phone: 812-275-3331 Fax: 812-276-1211 | |
Transitions Counseling & Support Services For Families, P.c. Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 1702 C St, Bedford, IN 47421 Phone: 812-275-7765 Fax: 812-275-6520 |